Rocuronium Carton1
Rocuronium Bromide Injection
Product Images NDC 68083-365
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 68083-365). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Rocuronium Carton2
This is a medicine called Rocuronium Bromide Injection that is available in a 100 mg/10 mL pack, with 10mg/mL potency. It is a paralyzing agent that should only be used intravenously and comes with a warning label. The text also includes some product codes and numbers.*
Rocuronium Structure1
Rocuronium Structure2
Rocuronium Structure3
Rocuronium Structure4
Rocuronium Vial Label1
NDC 68083-364-01 is a multiple dose vial containing 10 mg/mL of Rocuronium Bromide injection. This medication is a paralyzing agent that should only be used intravenously and must be kept refrigerated between 2-8°C (36-46°F) without freezing. Once removed from refrigeration and brought to room temperature, it must be used within 60 days. This product is sterile and non-pyrogenic, and its packaging is not made with natural rubber latex. However, it's essential to note that Rocuronium Bromide may cause respiratory arrest, and the medical facility must have respiratory support readily available. Additionally, the opened vials should be used within 30 days of opening. This product was manufactured by Gland Pharma Limited in Hyderabad, India.*
Rocuronium Vial Label2
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
